Marketing software outfit smartFOCUS (STF) has accepted a £25.3 million cash offer, backed by leading technology investor Francisco Partners.
The firm making the offer is newly incorporated Emailvision Holdings, but this is the holding company of the Emailvision Group - a worldwide leader in on-demand software with over 3,000 clients worldwide. AIM quoted smartFOCUS has had a patchy record since joining the market in 2004, but is a global provider of email and multi-channel marketing.
It provides detailed analysis and customer insight and in the year to 31 December boosted sales 17 per cent to £13.9 million as pre-tax profits soared 78 per cent to £872,000. The 25p a share cash bid represents a 61.3 per cent premium to the closing price on Friday, and has already received acceptances from 51.7 per cent of shareholders.
Growth Company Investor suggested backing the shares at 19p last March, so the news today is a welcome outcome for shareholders. Prior to the bid house broker Arbuthnot was forecasting 2011 pre-tax profits of £1.09 million and EPS of 0.8p. The recommended offer represents an exit multiple of just over 31 times earnings. Accept.
The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info
Latest small-cap and growth company news
Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.
One View listed on AIM via a reverse takeover back in March. It has developed software that provides retailers with a combined view of their customers history in both online and in-store shopping channels. This sort of digital engagement is a big opportunity for retailers to boost their sales.
Angle is making good progress with its ‘Parsortix’ system which uses a precision-etched cassette to ‘sieve’ patient blood samples and capture cancerous tumour cells. The first major trial is now underway in ovarian cancer, led by the University of Vienna.
Transportation software specialist Tracsis has won a significant contract in the US. This looks like it could be a breakthrough which opens up the vast North American railroad market to this Leeds based company.
ScS Group confirms it hasn't seen a slowdown in demand post-Brexit. Momentum has continued since the update in early June, with like-for-like sales order intake of 14.8 per cent for the first financial year ending in July.